Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
Tai‐Heng Chen
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3297-3297
Open Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

An Overview of the Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy
Yueyi Li, Hongyu Zeng, Yuhao Wei, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 5-6, pp. 180-191
Closed Access | Times Cited: 10
The Socio-Economic Burden of Spinal Muscular Atrophy: A Cost-of-Illness Study in Bulgaria
Elizabet Dzhambazova, Костадин Костадинов, Lilia Tsenkova-Toncheva, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 401-401
Open Access
Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications
Andrej Belančić, Tamara Janković, Elvira Meni Maria Gkrinia, et al.
Neurology International (2025) Vol. 17, Iss. 3, pp. 41-41
Open Access
Short review on determination of nusinersen for spinal muscular atrophy treatment
Karolina Ostrowska, Natalia Balińska, Sylwia Studzińska
Microchemical Journal (2025), pp. 113559-113559
Closed Access
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance
Andrej Belančić, Petar Mas, Lara Miletić, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3173-3173
Open Access
The respiratory impact of novel therapies for spinal muscular atrophy
Grace Paul, Courtney Gushue, Kavitha Kotha, et al.
Pediatric Pulmonology (2020) Vol. 56, Iss. 4, pp. 721-728
Closed Access | Times Cited: 25
Clinical and Functional Characteristics of a New Phenotype of SMA Type I among a National Sample of Spanish Children: A Cross-Sectional Study
Beatriz de-Andrés-Beltrán, Javier Güeita‐Rodríguez, Domingo Palacios‐Ceña, et al.
Children (2023) Vol. 10, Iss. 5, pp. 892-892
Open Access | Times Cited: 9
The dysregulation of lncRNAs by epigenetic factors in human pathologies
Yanli Zhang, Xiaocong Wang, Chen Zhang, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103664-103664
Closed Access | Times Cited: 9
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 9
Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy
Ana Letícia Amorim de Albuquerque, Júlia Kersting Chadanowicz, Giovanna Câmara Giudicelli, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 3
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals
Siyi Chen, Qi Mao, Hong Cheng, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Spinal muscular atrophy type 1 in the Caribbean: the first case report from the Dominican Republic
María Belén Martín-Sanz, Delvis Lucas-Muñoz, Manuel Colomé-Hidalgo
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)
Zhihua Feng, Steven Lam, Elena-Marie Sandino Tenn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8015-8015
Open Access | Times Cited: 19
Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy
Aleksandra Bieniaszewska, Magdalena Sobieska, Barbara Steinborn, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1005-1005
Open Access | Times Cited: 7
Gene transfer therapy in children with spinal muscular atrophy: A single‐center experience with a cohort of 25 children
Nidheesh Chencheri, Gail Alexander, Ahmed Nugud, et al.
Muscle & Nerve (2023) Vol. 68, Iss. 3, pp. 269-277
Closed Access | Times Cited: 7
The potential role of miRNA therapies in spinal muscle atrophy
Gayatri Gandhi, Syahril Abdullah, Agus Iwan Foead, et al.
Journal of the Neurological Sciences (2021) Vol. 427, pp. 117485-117485
Open Access | Times Cited: 15
Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
Andrés López‐Cortés, Gabriela Echeverría‐Garcés, María José Ramos-Medina
Biology (2022) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 11
Gene-based therapies for neuromuscular disorders
Edmar Zanoteli, Marcondes C. França, Wilson Marques
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 06, pp. 001-010
Open Access | Times Cited: 2
Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III
Mengnan Lu, Xueying Wang, Na Sun, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 2
Effects of nusinersen on motor function in children with spinal muscular atrophy: a retrospective study
Yuyi Chen, Dongling Yang, Xuelin Huang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1–3
Shijia Ouyang, Xiaoyin Peng, Wen‐Chen Huang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar
Nader Al‐Dewik, Tala Abuarja, Salma Younes, et al.
Personalized Medicine (2024), pp. 1-21
Closed Access | Times Cited: 2
A systematic review of economic evaluations of orphan medicines for the management of spinal muscular atrophy
Andrej Belančić, Andrea Katrin Faour, Elvira Meni Maria Gkrinia, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 2
Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers’ perspective: a two-part study
Tina Duong, Jessica Braid, Hannah Staunton, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14

Scroll to top